Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inci Yildirim

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
Antimicrobial Agents and Chemotherapy|May 25, 2021
Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric PatientsAntonio C Arrieta, Michael Neely, J Christopher Day, et al.
Open Forum Infectious Diseases|July 14, 2025
Viral Etiologies of Acute Respiratory Illness in Older Adults and of Congestive Heart Failure and Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization During 2 Prepandemic Respiratory SeasonsChris Choi, Gabriella Ess, Ashley Tippett, et al.
The New England Journal of Medicine|May 11, 2022
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of AgeC Buddy Creech, Evan Anderson, Vladimir Berthaud, et al.
Nature Medicine|January 20, 2022
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccinationEddy Pérez-Then, Carolina Lucas, Valter Silva Monteiro, et al.
NPJ Vaccines|December 23, 2024
A Phase 1 randomized trial of homologous and heterologous filovirus vaccines with a late booster doseChristina A Rostad, Inci Yildirim, Carol Kao, et al.
Nature Communications|October 31, 2025
Characterizing social behavior relevant for infectious disease transmission in four low- and middle-income countries, 2021-2023Kristin N Nelson, Moses C Kiti, Machi Shiiba, et al.
The Journal of Infection|July 3, 2018
The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysisEvelyn Balsells, Ron Dagan, Inci Yildirim, et al.
The Lancet. Microbe|May 1, 2025
The impact of orthopoxvirus vaccination and Mpox infection on cross-protective immunity: a multicohort observational studyJameson Crandell, Valter Silva Monteiro, Lauren Pischel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2024
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US AdultsChristina A Rostad, Robert L Atmar, Emmanuel B Walter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 2026
Respiratory Syncytial Virus Hospitalizations in Adults ≥50 Years of Age and Those with Congestive Heart Failure or Chronic Obstructive Pulmonary Disease Exacerbations, 2018-2020Ashley Tippett, Pragati V Prasad, Elizabeth Begier, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Antimicrobial Agents and Chemotherapy|May 25, 2021
Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric PatientsAntonio C Arrieta, Michael Neely, J Christopher Day, et al.
Open Forum Infectious Diseases|July 14, 2025
Viral Etiologies of Acute Respiratory Illness in Older Adults and of Congestive Heart Failure and Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization During 2 Prepandemic Respiratory SeasonsChris Choi, Gabriella Ess, Ashley Tippett, et al.
The New England Journal of Medicine|May 11, 2022
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of AgeC Buddy Creech, Evan Anderson, Vladimir Berthaud, et al.
Nature Medicine|January 20, 2022
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccinationEddy Pérez-Then, Carolina Lucas, Valter Silva Monteiro, et al.
NPJ Vaccines|December 23, 2024
A Phase 1 randomized trial of homologous and heterologous filovirus vaccines with a late booster doseChristina A Rostad, Inci Yildirim, Carol Kao, et al.
Nature Communications|October 31, 2025
Characterizing social behavior relevant for infectious disease transmission in four low- and middle-income countries, 2021-2023Kristin N Nelson, Moses C Kiti, Machi Shiiba, et al.
The Journal of Infection|July 3, 2018
The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysisEvelyn Balsells, Ron Dagan, Inci Yildirim, et al.
The Lancet. Microbe|May 1, 2025
The impact of orthopoxvirus vaccination and Mpox infection on cross-protective immunity: a multicohort observational studyJameson Crandell, Valter Silva Monteiro, Lauren Pischel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2024
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US AdultsChristina A Rostad, Robert L Atmar, Emmanuel B Walter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 2026
Respiratory Syncytial Virus Hospitalizations in Adults ≥50 Years of Age and Those with Congestive Heart Failure or Chronic Obstructive Pulmonary Disease Exacerbations, 2018-2020Ashley Tippett, Pragati V Prasad, Elizabeth Begier, et al.
Pageof 15